162 related articles for article (PubMed ID: 30782250)
1. Improved gastrointestinal stability of solid lipid nanoparticles using comb-shaped amphiphilic inulin derivatives.
Peng T; Guo F; Liang D; Gao Y; Zhang X; Qiu S; Liu J; Zhong H
Pharmazie; 2019 Jan; 74(1):47-53. PubMed ID: 30782250
[TBL] [Abstract][Full Text] [Related]
2. Enhanced storage stability of solid lipid nanoparticles by surface modification of comb-shaped amphiphilic inulin derivatives.
Peng TX; Liang DS; Guo F; Peng H; Xu YC; Luo NP; Zhang XY; Zhong HJ
Colloids Surf B Biointerfaces; 2019 Sep; 181():369-378. PubMed ID: 31170643
[TBL] [Abstract][Full Text] [Related]
3. Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies.
Wang S; Chen T; Chen R; Hu Y; Chen M; Wang Y
Int J Pharm; 2012 Jul; 430(1-2):238-46. PubMed ID: 22465546
[TBL] [Abstract][Full Text] [Related]
4. Formulation, optimization, and characterization of rifampicin-loaded solid lipid nanoparticles for the treatment of tuberculosis.
Chokshi NV; Khatri HN; Patel MM
Drug Dev Ind Pharm; 2018 Dec; 44(12):1975-1989. PubMed ID: 30058392
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporine a loaded solid lipid nanoparticles: optimization of formulation, process variable and characterization.
Varia JK; Dodiya SS; Sawant KK
Curr Drug Deliv; 2008 Jan; 5(1):64-9. PubMed ID: 18220553
[TBL] [Abstract][Full Text] [Related]
6. Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles.
Vivek K; Reddy H; Murthy RS
AAPS PharmSciTech; 2007 Oct; 8(4):E83. PubMed ID: 18181544
[TBL] [Abstract][Full Text] [Related]
7. Preparation, Characterization and Anti-Ulcer Efficacy of Sanguinarine Loaded Solid Lipid Nanoparticles.
Sun Q; Li W; Li H; Wang X; Wang Y; Niu X
Pharmacology; 2017; 100(1-2):14-24. PubMed ID: 28334726
[TBL] [Abstract][Full Text] [Related]
8. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration.
Song A; Zhang X; Li Y; Mao X; Han F
Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734
[TBL] [Abstract][Full Text] [Related]
9. Systematic approach for the formulation and optimization of atorvastatin loaded solid lipid NANOAPARTICLES using response surface methodology.
Sarangi B; Jana U; Sahoo J; Mohanta GP; Manna PK
Biomed Microdevices; 2018 Jun; 20(3):53. PubMed ID: 29946758
[TBL] [Abstract][Full Text] [Related]
10. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles.
Das S; Ng WK; Tan RB
Nanotechnology; 2014 Mar; 25(10):105101. PubMed ID: 24531790
[TBL] [Abstract][Full Text] [Related]
11. Impact of Pluronic F-68 vs Tween 80 on Fabrication and Evaluation of Acyclovir SLNs for Skin Delivery.
Bhupinder K; Newton MJ
Recent Pat Drug Deliv Formul; 2016; 10(3):207-221. PubMed ID: 27456458
[TBL] [Abstract][Full Text] [Related]
12. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
Das S; Ng WK; Tan RB
Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
[TBL] [Abstract][Full Text] [Related]
13. Diazepam-loaded solid lipid nanoparticles: design and characterization.
Abdelbary G; Fahmy RH
AAPS PharmSciTech; 2009; 10(1):211-9. PubMed ID: 19277870
[TBL] [Abstract][Full Text] [Related]
14. Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid.
Lim SJ; Kim CK
Int J Pharm; 2002 Aug; 243(1-2):135-46. PubMed ID: 12176302
[TBL] [Abstract][Full Text] [Related]
15. Design and evaluation of itraconazole loaded solid lipid nanoparticulate system for improving the antifungal therapy.
Mukherjee S; Ray S; Thakur RS
Pak J Pharm Sci; 2009 Apr; 22(2):131-8. PubMed ID: 19339221
[TBL] [Abstract][Full Text] [Related]
16. Physicochemical Characterization of Chitosan-Decorated Finasteride Solid Lipid Nanoparticles for Skin Drug Delivery.
Sohaib M; Shah SU; Shah KU; Shah KU; Khan NR; Irfan MM; Niazi ZR; Alqahtani AA; Alasiri A; Walbi IA; Mahmood S
Biomed Res Int; 2022; 2022():7792180. PubMed ID: 35971450
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity screening of emulsifiers for pulmonary application of lipid nanoparticles.
Steiner V; Öhlinger K; Corzo C; Salar-Behzadi S; Fröhlich E
Eur J Pharm Sci; 2019 Aug; 136():104968. PubMed ID: 31233864
[TBL] [Abstract][Full Text] [Related]
18. Improved anti-hyperlipidemic activity of Rosuvastatin Calcium via lipid nanoparticles: Pharmacokinetic and pharmacodynamic evaluation.
Dudhipala N; Veerabrahma K
Eur J Pharm Biopharm; 2017 Jan; 110():47-57. PubMed ID: 27810472
[TBL] [Abstract][Full Text] [Related]
19. Optimization of process variables of zanamivir-loaded solid lipid nanoparticles and the prediction of their cellular transport in Caco-2 cell model.
Shi LL; Cao Y; Zhu XY; Cui JH; Cao QR
Int J Pharm; 2015 Jan; 478(1):60-69. PubMed ID: 25448568
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxicity of solid lipid nanoparticles as a function of the lipid matrix and the surfactant.
Müller RH; Rühl D; Runge S; Schulze-Forster K; Mehnert W
Pharm Res; 1997 Apr; 14(4):458-62. PubMed ID: 9144731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
